Barely Significant
← all excerpts

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients.

Radiat Oncol · 2014 · PMC4307885 · PMID 25529015

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
Fisher’s exact test showed a trend for a correlation between recurrence pattern and PTV size (as binary variable with 75 ml as threshold); 5 recurrences were marginal/ex-field compared to 2 in-field recurrences for PTV sizes smaller than 75 ml whereas larger PTV sizes were associated with a high in-field recurrence rate, 17 in-field vs. 7 ex-field recurrences (p = 0.078).

also in 53,322 other papers

marginally significantno p-value reported
Recent prospective phase III trials (AVAglio & RTOG 0825) were designed to prove the efficacy of TMZ based radio-chemotherapy with bevacizumab as first-line therapy but failed to show a survival benefit whereas significant and marginally significant progression-free survival benefits have been observed [ 23 , 24 ].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.